p38 MAP Kinase Regulates Stem Cell Apoptosis in Human Hematopoietic Failure

Li Zhou, Joanna Opalinska and Amit Verma

volume 6 | issue 5

1 March 2007
Pages: 534 - 537

We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:

Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.

Myelodysplastic syndromes (MDS) are clonal stem cell disorders that lead to ineffective hematopoiesis and are common causes of low blood counts in the elderly. The exact molecular mechanisms regulating increased stem apoptosis in these disorders are not well defined. p38 MAPK activation is important in regulating the growth inhibitory signals of TNF-α, TGF-β and Interferons on human hematopoiesis. Our findings show that p38 MAPK is overactivated in myelodysplasia bone marrows and regulates hematopoietic stem cell apoptosis. Inhibition of p38 MAPK by genetic or pharmacologic means decreases apoptosis and stimulates in vitro hematopoiesis from primary MDS hematopoietic progenitors. These studies point to the potential efficacy of selective p38α inhibitor, SCIO-469, in human bone marrow failure.

Authors

Li Zhou

Albert Einstein College of Medicine; Bronx NY, USA

Joanna Opalinska

Albert Einstein College of Medicine; Bronx NY, USA and Department of Hematology, Pomeranian Medical University; Szczecin, Poland

Amit Verma